Admin Overview
Platform-wide metrics and activity across all tenants
Recent Activity
FDA safety alert for NCT04819022
WATCHDOG at Tampa General resumed after restart
New tenant: pharma-north registered
PubMed: Phase III results for competitor trial
RECRUITER dispatched 12 outreach messages
42 X.com signals processed, 3 auto-pursued
GUARDIAN flagged protocol deviation at Site 003
ClinicalTrials.gov: 2 new competitor enrollments
Monte Carlo run #847 finished, 94.2% enrollment confidence
SCHEDULER optimized visit calendar for Q2
FAERS signal: elevated AE reports for class drug
Site 007 CPE exceeded threshold ($4,200 vs $3,800 target)
QUARTERMASTER at Orlando Health reporting nominal
FDA eCFR scan: 0 new regulatory changes detected
INTAKE processed 8 new screening forms
PubMed: Meta-analysis relevant to AD-SPARK endpoints
Feature flag updated: prediction_markets=true for civia-health
WATCHDOG detected enrollment velocity drop at Site 001
X.com: Patient advocacy group mention (relevance 8.2)
Digital twin scenario: accelerated enrollment model